Company Filing History:
4 out of 229 
1 out of 136 
Years Active: 1985-1993
Title: Ichitomo Miwa: Innovator in Hydantoin Derivatives
Introduction: Ichitomo Miwa is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on hydantoin derivatives. With a total of 5 patents, his innovations focus on developing compounds that have therapeutic applications, especially in the treatment of diabetes and its complications.
Latest Patents: Ichitomo Miwa's latest patents revolve around novel hydantoin derivatives. These inventions include processes for producing hydantoin derivatives and pharmaceutical compositions that utilize these compounds as aldose reductase inhibitors. The compounds exhibit strong inhibitory activity against aldose reductase, making them valuable for treating and preventing various diabetic complications. Additionally, these hydantoin derivatives demonstrate hypoglycemic and hypolipidemic properties, indicating their potential in managing diabetes mellitus and associated conditions.
Career Highlights: Throughout his career, Ichitomo Miwa has worked with prominent pharmaceutical companies, including Mochida Pharmaceutical Co., Ltd. and Kaken Pharmaceutical Company, Ltd. His expertise in medicinal chemistry and drug development has led to advancements in the treatment of diabetes and related disorders.
Collaborations: Ichitomo Miwa has collaborated with esteemed colleagues such as Jun Okuda and Ei Mochida. These partnerships have fostered innovation and contributed to the successful development of his patented compounds.
Conclusion: Ichitomo Miwa's work in hydantoin derivatives showcases his commitment to advancing pharmaceutical science. His inventions hold promise for improving the lives of individuals affected by diabetes and its complications.